The VATRAC trial confirms VivAer's safety and efficacy in treating nasal airway obstruction caused by nasal valve collapse. Patients treated with VivAer showed significant improvement in symptoms compared to the control group, with superior responder rates and symptom reduction.
A new study reveals that common OTC drugs for sore throat are more harm than good, causing inflammation and damage to upper respiratory cells. Biovanta, a naturally derived drug, has been shown to reduce inflammation and treat respiratory inflammation effectively.
A groundbreaking study published in PNAS used a multi-modal precision health platform to identify adults at risk of key health conditions, including cancer, heart disease, and neurological disorders. The study found that integrating whole-genome sequencing with advanced imaging and blood metabolites led to clinically significant findin...
The ASTER Trial shows no significant difference in revascularization rate and safety between Penumbra's aspiration system and stent retrievers for acute ischemic stroke patients with large vessel occlusions. The study provides evidence supporting the use of aspiration as a frontline thrombectomy approach.
The Penumbra 3D Trial demonstrated non-inferiority in safety and efficacy of a next-generation stent retriever when used with aspiration devices compared to solo aspiration use. Revascularization rates were comparable between the two groups, suggesting frontline effectiveness of the combined therapy.
A randomized clinical trial found intra-arterial treatment improved functional outcome by 71% over medical management with tPA alone. The study showed benefits for all ages, including the elderly, and demonstrated effectiveness up to 6 hours after stroke onset.